Submission Details
| 510(k) Number | K954188 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 06, 1995 |
| Decision Date | November 03, 1995 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K954188 is an FDA 510(k) clearance for the OPTICLONE IGG1 FITC/IGG2A PE ISOTYPIC CONTROL, a Counter, Differential Cell (Class II — Special Controls, product code GKZ), submitted by Immunotech Corp. (Westbrook, US). The FDA issued a Cleared decision on November 3, 1995, 58 days after receiving the submission on September 6, 1995. This device falls under the Hematology review panel. Regulated under 21 CFR 864.5220.
| 510(k) Number | K954188 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 06, 1995 |
| Decision Date | November 03, 1995 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GKZ — Counter, Differential Cell |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.5220 |